A critical aspect responsible for the tumor selectivity of RNA-based oncolytic viruses is the acquired deficiencies in antiviral type I interferon signaling (IFN) pathways within tumor cells, contributing to evasion from immune surveillance, while also facilitating viral propagation [6]. The gene discussed is IFNA1; the disease is neoplasm.